Abstract
Objective: To review the mechanisms underlying the metabolic syndrome, or syndrome X, in humans, and to delineate dietary and environmental strategies for its prevention.
Design: Review of selected papers of the literature.
Results: Hyperinsulinemia and insulin resistance play a key role in the development of the metabolic syndrome. Strategies aimed at reducing insulin resistance may be effective in improving the metabolic syndrome. They include low saturated fat intake, consumption of low-glycemic-index foods, physical exercise and prevention of obesity.
Conclusions: Future research, in particular the genetic basis of the metabolic syndrome and the interorgan interactions responsible for insulin resistance, is needed to improve therapeutic strategies for the metabolic syndrome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andersson A, Sjödin A, Hedman A, Olsson R, Vessby B . 2000 Fatty acid profile of skeletal muscle phospholipids in trained and untrained young men Am. J. Physiol. Endocrinol. Metab. 279: E744–E751
Anonymous . 2000 Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity Arch. Intern Med. 160: 898–904
Bailey CJ, Turner RC . 1996 Metformin New Engl. J. Med. 29: 574–579
Baron AD . 1993 Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone Baillieres Clin. Endocrinol. Metab. 7: 961–987
Battilana P, Seematter G, Schneiter TP, Jéquier E, Tappy L . 2001 Effects of free fatty acids on insulin sensitivity and haemodynamics during mental stress J. Clin. Endocrinol. Metab. 86: 124–128
Battilana P, Ornstein K, Minehira K, Schwarz JM, Acheson K, Schneiter TP, Burri J, Jequier E, Tappy L . 2001 Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men Eur. J. Clin. Nutr. 55: 327–333
Bjorntorp P, Rosmond R . 2000 Neuroendocrine abnormalities in visceral obesity Int. J Obes. 24: (Suppl. 2): 80–85
Blundell JE, Lawton CL, Cotton JR, Macdiarmid JI . 1996 Control of human appetite: implications for the intake of dietary rat A. Rev. Nutr. 16: 285–319
Borghouts LB, Keizer HA . 2000 Exercise and insulin sensitivity: a review Int. J. Sport Med. 21: 1–12
Campbell LV, Marmot PE, Dyer JA, Borkman M, Storlien LH . 1994 The high-monounsaturated rat diet as a practical alternative for-NIDDM Diabetes Care 17: 177–182
Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O, Reitman ML . 2000 Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones J. Clin. Invest. 106: 1221–1228
Day C . 1999 Thiazolidinediones: a new class of antidiabetic drugs Diabetic Med. 16: 179–192
DeFronzo RA . 1988 The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM Diabetes 37: 667–687
DeFronzo RA . 1991 Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14: 173–194
Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry JD . 2001 Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats Diabetes 50: 123–130
Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI . 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity J. Clin. Invest. 103: 253–259
Ellis BA, Poynten A, Lowry AJ, Furler SM, Chisholm DJ, Kraegen EW, Cooney GJ . 2000 Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle Am. J. Physiol. Endocrinol. Metab. 279: E554–E560
Felber JP, Acheson KJ, Tappy L . 1992 From Obesity to Diabetes. Chichester: John Wiley
Golan M, Fainaru M, Weizman A . 1998 Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change Int. J. Obes. Relat. Metab. Disord. 22: 1217–1224
Hollenbeck CB . 1993 Dietary fructose effects on lipoprotein metabolism and risk fu¨r coronary artery disease Am. J. Clin. Nutr. 58: (Suppl.): 800–809
Kelley DE, Simoneau J-A . 1997 Mechanisms of insulin resistance in obesity In: Clinical Research in Diabetes and Obesity ed. B Draznin & R Rizza pp 57–72 Totawa, NY: Humana Press
Kersten S, Desvergne B, Wahli W . 2000 Roles of PPARs in health and disease Nature 405: 421–424
Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI . 1999 Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study Diabetologia 42: 113–116
Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T . 1999 PPAR gamma mediates high-rat diet-induced adipocyte hypertrophy and insulin resistance Mol. Cell 4: 597–609
Marshall JA, Bessesen DH, Hamman RF . 1997 High saturated rat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study Diabetologia 40: 430–438
Parks EJ, Hellerstein MK . 2000 Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms Am. J. Clin. Nutr. 71: 412–433
Randle P, Garland P, Hales C, Newsholme E . 1963 The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus Lancet 1: 785–789
Ravussin E, Gautier JF . 1999 Metabolic predictors of weight gain Int. J. Obes. Relat. Metab. Disord. 23(1): 47–41
Reaven GM . 1991 Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models Diabetes Care 14: 195–202
Reaven GM . 1997 Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against Curr. Opinion Lipidol. 8: 23–27
Reaven GM . 1999 Insulin resistance: a chicken that has come to roost Ann. NY Acad. Sci. 892: 45–57
Reaven GM, Lithell H, Landsberg L . 1996 Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system New Engl. J. Med. 334: 374–381
Reitman ML, Mason MM, Moitra J, Gavrilova O, Marcus-Samuels B, Eckhaus M, Vinson C . 1999 Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes Ann. NY Acad. Sci. 892: 289–296
Riccardi G, Rivellese AA . 1991 Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients Diabetes Care 14: 1115–1125
Riccardi G, Rivellese AA . 2000 Dietary treatment of the metabolic syndrome—the optimal diet Br. J. Nutr. 83(1): 143–148
Ruderman NB, Saha AK, Vavvas D, Witters LA . 1999 Malonyl–CoA, fuel sensing, and insulin resistance Am. J. Physiol. 276: E1–E18
Sakul H, Pratley R, Cardon L, Ravussin E, Mott D, Bogardus C . 1997 Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians Am. J. Hum. Genet. 60: 651–656
Seematter G, Guenat E, Schneiter P, Cayeux C, Jéquier E, Tappy L . 2000 Effects of mental stress on insulin-mediated glucose metabolism and energy expenditure in lean and obese women Am. J. Physiol. 279: E799–E805
Shimomura L, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL . 2000 Decreased IRS-2 and increased SREBP-l c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice Mol. Cell 6: 77–86
Shulman GI . 2000 Cellular mechanisms of insulin resistance J. Clin. Invest. 106: 171–176
Steinberg HO, Baron A . 1997 Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation J. Clin. Invest. 100: 1230–1239
Tappy L, Felber JP, Jéquier E . 1991 Energy and substrate metabolism in obesity and postobese state Diabetes Care 14: 1180–1188
Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapseil LC, Nälsén C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson I-B, Storlien LH . 2001 Substituting dietary saturated fu¨r monounsaturated rat impairs insulin sensitivity in healthy men and women: the KANWU study Diabetologia 44: 312–319
Winder WW, Hardie DG . 1999 AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes Am. J. Physiol. 277: E1–E10
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Minehira, K., Tappy, L. Dietary and lifestyle interventions in the management of the metabolic syndrome: present status and future perspective. Eur J Clin Nutr 56, 1264–1269 (2002). https://doi.org/10.1038/sj.ejcn.1601645
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601645
Keywords
This article is cited by
-
Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment
Nature Communications (2018)
-
Gender-dependent associations between socioeconomic status and metabolic syndrome: a cross-sectional study in the adult Saudi population
BMC Cardiovascular Disorders (2014)
-
Gender, socio-economic status and metabolic syndrome in middle-aged and old adults
BMC Public Health (2008)
-
Low-carbohydrate or low-fat diets for the metabolic syndrome?
Current Diabetes Reports (2006)
-
Does metabolic syndrome mitigate weight loss in overweight Mexican American women treated for 1-year with orlistat and lifestyle modification?
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2006)